We are live on ! Find out more
CNTA

Centessa Pharmaceuticals
CNTA

Delisted

CNTA was delisted on the 23rd of June, 2026.

Back to rankings

50 hedge funds and large institutions have $1.05B invested in Centessa Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 50 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

54.23% more ownership

Funds ownership: 0% → 54.23% (+54%)

Holders
50
Holders Change
+50
Holders Change %
–
% of All Funds
0.87%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.05%
New
50
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MVM
Medicxi Ventures Management
Jersey
+$421M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$134M
3
VVA
Vida Ventures Advisors
Massachusetts
+$92.4M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$47.3M
5
SB
Samsara BioCapital
California
+$36.1M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MVM
1
Medicxi Ventures Management
Jersey
$398M +$421M +17,923,892 New
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$120M +$134M +5,680,933 New
VVA
3
Vida Ventures Advisors
Massachusetts
$87.3M +$92.4M +3,931,818 New
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$43.9M +$47.3M +2,011,073 New
SB
5
Samsara BioCapital
California
$34.1M +$36.1M +1,537,533 New
GA
6
General Atlantic
New York
$33.3M +$35.3M +1,500,000 New
CAM
7
Cormorant Asset Management
Massachusetts
$31.1M +$33.5M +1,427,273 New
RCM
8
RA Capital Management
Massachusetts
$28.4M +$30.1M +1,280,300 New
VA
9
VR Adviser
New York
$25M +$26.5M +1,127,272 New
Wellington Management Group
10
Wellington Management Group
Massachusetts
$24.6M +$26M +1,106,577 New
DCM
11
Driehaus Capital Management
Illinois
$22.2M +$23.5M +999,861 New
LGM
12
Logos Global Management
California
$20.9M +$22.1M +939,545 New
Franklin Resources
13
Franklin Resources
California
$20.5M +$21.7M +922,700 New
BC
14
Boxer Capital
California
$20.1M +$21.3M +904,227 New
WP
15
Woodline Partners
California
$18.3M +$19.3M +822,518 New
Fidelity Investments
16
Fidelity Investments
Massachusetts
$17.5M +$18.6M +790,000 New
EC
17
EcoR1 Capital
California
$16.8M +$17.7M +754,545 New
Millennium Management
18
Millennium Management
New York
$12.2M +$12.9M +548,452 New
ACA
19
Avoro Capital Advisors
New York
$11.1M +$11.8M +500,000 New
Citadel Advisors
20
Citadel Advisors
Florida
$10.1M +$10.7M +456,233 New
BBA
21
Baker Bros. Advisors
New York
$8.88M +$9.4M +400,000 New
American Century Companies
22
American Century Companies
Missouri
$8.25M +$8.73M +371,504 New
Ensign Peak Advisors
23
Ensign Peak Advisors
Utah
$7.77M +$8.23M +350,000 New
Jennison Associates
24
Jennison Associates
New York
$6.66M +$7.05M +300,000 New
MIM
25
Monashee Investment Management
Massachusetts
$2.89M +$3.06M +130,000 New
1
2

CNTA Hedge Fund Activity: Q2 2021 in Review

50 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Centessa Pharmaceuticals (CNTA) for Q2 2021, worth a combined $1.05B.

Buyers outnumbered sellers: 50 funds opened new CNTA positions and 0 closed out — a net gain of 50 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Medicxi Ventures Management, opening a new position worth an estimated $421M.

  • 50 institutional investors held Centessa Pharmaceuticals (CNTA) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $1.05B of Centessa Pharmaceuticals stock for Q2 2021.
  • 50 funds opened new Centessa Pharmaceuticals positions in Q2 2021 and 0 closed out, a net change of +50 holders.
  • The largest Centessa Pharmaceuticals buyer in Q2 2021 was Medicxi Ventures Management, an estimated $421M added.

Based on aggregated 13F filings for Q2 2021.